As pharmacists, epidemiologists and clinicians, we are continuously monitoring and validating the latest guidance as regulations, science and clinical care changes.

Our commitment — helping your team quickly adopt and transform the latest evidence-based recommendations into practice.

Clinical team discussing program results

Our role in your success

  • We conduct proactive reviews of industry-leading guidance from organizations that include the CDC, SHEA, APIC, USP, FDA, CriticalPoint, IDSA, ASHP, UpToDate, Lexicomp and others, as well as Wolters Kluwers’ network of the world’s top medical specialists.
  • We work closely with you to curate and adopt the right evidence-based guidance and best practices, as well as perform assessments to help achieve your program’s strategic priorities.
  • We help you collaborate across teams to ensure our applications’ content, alerts and analytics sustainably flow seamlessly in your team’s daily workflow.

Working together, we advance healthcare programs that are essential to improving safety, quality, performance and overall patient care.

Our commitment to customer success

Big or small projects—we make it easy to implement our solutions and optimize the impact on your program. 

How We Work

Our clinical experts

Annie Lambert
Annie Lambert, PharmD, BCSCP
Clinical Program Manager for Compliance Solutions
Compliance Solution Clinical Program Manager Annie Lambert, PharmD, BCSCP is committed to providing up-to-date USP content and expert compliance guidance, and to work with you to optimize the use of our Simplifi+ pharmacy compliance solutions.
View Full Bio
Jennifer Smith, PharmD, BCSCP
Jennifer Smith, PharmD, BCSCP
Clinical Program Manager, Simplifi+
Jennifer Smith, PharmD, BSCP serves as Clinical Program Manager for Wolters Kluwer Compliance Solutions. She has over 18 years of hospital pharmacy experience and has spent the last 5 years specializing in sterile compounding.
View Full Bio
Matthew-Weissenbach
Matthew Weissenbach, DrPH, CPH, CIC, FAPIC
Senior Director of Clinical Affairs
Dr. Matt Weissenbach is responsible for directing clinician efforts toward the design, development, implementation and support of Wolters Kluwer Clinical Surveillance software solutions.
View Full Bio
Stacey-McCoy
Stacey McCoy, PharmD, MS, BCPS
Pharmacy Clinical Program Manager

Dr. Stacey McCoy has over 20 years of experience as a clinical pharmacist. Her most recent clinical practice included more than 12 years of experience as an adult emergency medicine specialist.

View Full Bio
Steve-Mok
Steve Mok, PharmD, MBA, BCPS, BCIDP
Associate Director, Pharmacy Consulting
Dr. Steve Mok has over a decade of experience in the areas of antimicrobial stewardship, infectious diseases and clinical pharmacy management. He has practiced in a variety of settings.
View Full Bio
Rich Dion PharmD
Richard Dion, PharmD
Pharmacy Clinical Program Manager

Dr. Richard Dion has 15 years of experience in the practice areas of medication use safety, pharmacy informatics and clinical decision support in varied settings.

View Full Bio
Karyn Wentz
Karyn Wentz, MSN, RN, CPN
Nurse Informaticist
Karyn Wenttz is a Nurse Informaticist for Clinical Surveillance & Compliance, Wolters Kluwer, Health .
View Full Bio
Gordon Watkins
Gordon Watkins, PharmD
Specialized Consulting Manager
Dr. Gordon Watkins has over 8 years of experience in institutional pharmacy clinical practice and operations, most specifically in implementing and optimizing pharmacy technology solutions.
View Full Bio
Karen Jones Headshot
Karen Jones, MPH, RN, CIC, LTC-CIP, FAPIC
Clinical Program Manager, Infection Prevention
Karen Jones is responsible for the development, design, and implementation of evidence-based clinical content and support for infection prevention leaders.
View Full Bio
Sara Xiong Headshot
Sara Xiong¸CPhT
Specialized Consultant – Pharmacy Compliance
Sara Xiong has 10 years of experience as a pharmacy technician, specializing in sterile compounding and pharmacy purchasing and inventory management. 
View Full Bio
Brenda Omondi
Brenda Omondi, MD, MHI
Clinical Informaticist
Dr. Brenda Omondi is a clinical informaticist responsible for Sentri7 Sepsis Monitor's clinical content development, updating and maintenance of clinical functionality, and case reviews and analysis.
View Full Bio
Helene Chaconas
Helene Chaconas, PharmD
Specialized Consulting Manager
Helene specializes in formulary management and optimization, drug information, pain management and anesthesia practice, and rare disease/ultra-high-cost therapeutics.
View Full Bio
Russ Nix professional headshot
Russ Nix
Consulting Associate Director at Wolters Kluwer, Health
Russ Nix has 25 years of investigations experience in both public and private sectors. He has worked in law enforcement as an undercover narcotics agent before transitioning to healthcare investigations. Russ has created healthcare drug diversion programs from the ground up, leveraging his knowledge and experience to address healthcare drug diversion and the opioid crisis through best practices and proactive approaches.
View Full Bio

Expert Insights

  • Article
    Health
    Updated April 30, 2025

    How to register intent to participate in NHSN AUR

    Register your hospital's intent to participate in the mandatory NHSN AUR data submission for CMS’s Promoting Interoperability program to avoid significant financial implications.
    Learn More
  • Article
    Health
    March 04, 2025

    Sterile compounding facility shutdown procedures for power loss events

    Are you prepared if a power outage disrupts your hospital’s operations? A facility needs to have a sound Standard of Operating Procedures (SOPs) ready for planned or unplanned power loss.
    Learn More
  • Article
    Health
    February 28, 2025

    Assessment of risk USP 800: Strategies for handling hazardous drugs safely

    USP 800 sets standards to protect healthcare workers, patients, and the environment from hazardous drug (HD) exposure. Covering HD handling from storage to disposal, it became enforceable on Nov 1, 2023, alongside USP 795 and USP 797.
    Learn More
  • Article
    Health
    February 28, 2025

    Understanding USP 797 Beyond-Use Dates (BUDs) of Compounded Sterile Preparations (CSPs)

    The assignment of the beyond-use date (BUD) of a compounded sterile preparation (CSP) is a primary driver for patient safety. In the revised USP 797 (2023), additional factors are used to determine the appropriate BUD.
    Learn More
Back To Top